Mark E. Hwang
Columbia University Medical Center
9 Papers
2 Citations
Mark E. Hwang is an academic researcher from Columbia University Medical Center. The author has contributed to research in topics: Medicine & Prostate cancer. The author has an hindex of 5, co-authored 9 publications. Previous affiliations of Mark E. Hwang include Columbia University.
Chat about Author
Papers
Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes.
Mark E. Hwang,M. Mayeda,Maria Liz,Brenda Goode-Marshall,Lissette Gonzalez,Carl D. Elliston,Catherine S. Spina,Oscar A. Padilla,Sven Wenske,I. Deutsch +9 more
TL;DR: Periprostatic hydrogel placement followed by prostate SBRT resulted in minimal GI toxicity, and favorable early oncologic outcomes, indicating that SBRt with peripro static spacer is a well-tolerated, safe, and convenient treatment option for localized prostate cancer.
A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy
Mark E. Hwang,Paul J. Black,Carl D. Elliston,Brian A Wolthuis,Deborah R. Smith,Cheng-Chia Wu,Sven Wenske,I. Deutsch +7 more
TL;DR: The novel parameter θ*hydrogel volume describes a large proportion of rectum dosimetric benefit derived from hydrogel placement, and can be used to assess the learning curve phenomenon for hydrogels placement.
Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development.
Anurag Saraf,Christopher S. Grubb,Mark E. Hwang,Cheng Hung Tai,Cheng-Chia Wu,Ashish Jani,M.E. Lapa,J.I.S. Andrews,Sierra Vanderkelen,Steven R. Isaacson,Adam M. Sonabend,Sameer A. Sheth,Guy M. McKhann,Michael B. Sisti,Jeffrey N. Bruce,Simon K. Cheng,Eileen P. Connolly,Tony J. C. Wang +17 more
TL;DR: A retrospectively reviewed all BCBM patients treated with brain radiotherapy at the authors' institution from 1997 to 2015 to find patients with breast cancer risk factors associated with rapid development of BCBM could potentially benefit from early brain metastasis screening.
18
Temporalis muscle width as a measure of sarcopenia correlates with overall survival in patients with newly diagnosed glioblastoma
Kristin Hsieh,Mark E. Hwang,Gabrielle Estevez-Inoa,Akshay V. Save,Anurag Saraf,Catherine S. Spina,Simon K. Cheng,Tony J. C. Wang,Cheng-Chia Wu +8 more
TL;DR: A method to reproducibly quantify sarcopenia using the temporalis muscle and correlation with overall survival (OS) in GBM patients is developed and results suggest sarc Openia and TMW correlate with GBM OS.
15
Single institution validation of a modified graded prognostic assessment of patients with breast cancer brain metastases.
C.H. Tai,Cheng-Chia Wu,Mark E. Hwang,Anurag Saraf,Christopher S. Grubb,Ashish Jani,M.E. Lapa,J.I.S. Andrews,Steven R. Isaacson,Adam M. Sonabend,Sameer A. Sheth,Guy M. McKhann,Michael B. Sisti,Jeffrey N. Bruce,Simon K. Cheng,Eileen P. Connolly,Tony J. C. Wang +16 more
TL;DR: The inclusion of number of brain metastases into the modified breast GPA index improved prognosis, thus validating the use of themodified breast GPA in prognosticating patient outcome.
11